SEC Comment Letter 0000000000-23-002723 to Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc.
Date: March 17, 2023 · CIK: 0001411690 · Accession: 0000000000-23-002723
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-270459
Letter
United States securities and exchange commission logo March 17, 2023 R. Erik Holmlin, Ph.D. President and Chief Executive Officer Bionano Genomics, Inc. 9540 Towne Centre Drive, Suite 100 San Diego, California 92121 Re:Bionano Genomics, Inc. Registration Statement on Form S-3 Filed March 10, 2023 File No. 333-270459 Dear R. Erik Holmlin: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Phillip McGill, Esq.
Show Raw Text
United States securities and exchange commission logo
March 17, 2023
R. Erik Holmlin, Ph.D.
President and Chief Executive Officer
Bionano Genomics, Inc.
9540 Towne Centre Drive, Suite 100
San Diego, California 92121
Re:Bionano Genomics, Inc.
Registration Statement on Form S-3
Filed March 10, 2023
File No. 333-270459
Dear R. Erik Holmlin:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Phillip McGill, Esq.